Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert J de Winter

Showing results (451-460 of 467) with videos related to

Pageof 47
Sort By:
European Heart Journal|August 24, 2018
Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysisCarlos Collet, Yoshinobu Onuma, Jeroen Sonck, et al.
Journal of the American Heart Association|January 12, 2024
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality RiskMarie de Bakker, Niels T B Scholte, Rohit M Oemrawsingh, et al.
JACC. Cardiovascular Interventions|June 6, 2020
Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 ValvesRodrigo Modolo, Chun Chin Chang, Mohammad Abdelghani, et al.
Circulation|December 29, 2018
High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary SyndromeRohit M Oemrawsingh, K Martijn Akkerhuis, Maarten de Mulder, et al.
The American Journal of Cardiology|May 19, 2020
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)Jaya Chandrasekhar, Samantha Sartori, Melissa B Aquino, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 9, 2020
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO CollaborationJaya Chandrasekhar, Doreen Zeebregts, Deborah N Kalkman, et al.
Cardiovascular Drugs and Therapy|January 30, 2021
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO CollaborationJaya Chandrasekhar, Vera C de Winter, Deborah N Kalkman, et al.
The International Journal of Cardiovascular Imaging|March 27, 2019
The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trialRuben Y G Tijssen, Laura S M Kerkmeijer, Yuki Katagiri, et al.
Heart (British Cardiac Society)|November 11, 2010
Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studiesDouwe Pons, Stella Trompet, Anton J M de Craen, et al.
European Heart Journal. Acute Cardiovascular Care|April 25, 2023
Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohortMuhammed T Gürgöze, K Martijn Akkerhuis, Rohit M Oemrawsingh, et al.
Pageof 47

Showing results (451-460 of 467) with videos related to

Sort By:
Pageof 47
European Heart Journal|August 24, 2018
Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysisCarlos Collet, Yoshinobu Onuma, Jeroen Sonck, et al.
Journal of the American Heart Association|January 12, 2024
Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality RiskMarie de Bakker, Niels T B Scholte, Rohit M Oemrawsingh, et al.
JACC. Cardiovascular Interventions|June 6, 2020
Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 ValvesRodrigo Modolo, Chun Chin Chang, Mohammad Abdelghani, et al.
Circulation|December 29, 2018
High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary SyndromeRohit M Oemrawsingh, K Martijn Akkerhuis, Maarten de Mulder, et al.
The American Journal of Cardiology|May 19, 2020
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)Jaya Chandrasekhar, Samantha Sartori, Melissa B Aquino, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 9, 2020
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO CollaborationJaya Chandrasekhar, Doreen Zeebregts, Deborah N Kalkman, et al.
Cardiovascular Drugs and Therapy|January 30, 2021
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO CollaborationJaya Chandrasekhar, Vera C de Winter, Deborah N Kalkman, et al.
The International Journal of Cardiovascular Imaging|March 27, 2019
The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trialRuben Y G Tijssen, Laura S M Kerkmeijer, Yuki Katagiri, et al.
Heart (British Cardiac Society)|November 11, 2010
Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studiesDouwe Pons, Stella Trompet, Anton J M de Craen, et al.
European Heart Journal. Acute Cardiovascular Care|April 25, 2023
Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohortMuhammed T Gürgöze, K Martijn Akkerhuis, Rohit M Oemrawsingh, et al.
Pageof 47